74.51
Finanzdaten der Utah Medical Products Inc-Aktie (UTMD)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
2.21%
8.529
|
8.722 | 9.044 | 9.812 | 9.953 |
| Cost Of Revenue |
9.62%
3.771
|
3.44 | 3.781 | 4.208 | 4.358 |
| Gross Profit |
9.92%
4.758
|
5.282 | 5.264 | 5.604 | 5.595 |
|
|
22.38%
2.109
|
2.717 | - | 2.993 | 2.399 |
| Operating Income/Loss |
3.27%
2.649
|
2.565 | 2.441 | 2.611 | 3.196 |
| Income/Loss From Continuing Operations Before Tax |
3.27%
3.286
|
3.182 | 3.106 | 3.309 | 3.836 |
| Income Tax Expense/Benefit, Deferred |
86.62%
-0.021
|
-0.157 | 0.027 | -0.281 | -0.151 |
| Income Tax Expense/Benefit |
3.81%
0.60
|
0.578 | 0.54 | 0.678 | 0.788 |
| Net Income/Loss |
3.15%
2.686
|
2.604 | 2.565 | 2.631 | 3.048 |
| Basic Average Shares |
0.03%
3.184
|
3.185 | - | 3.207 | 3.246 |
| Diluted Average Shares |
0.03%
3.184
|
3.185 | - | 3.207 | 3.246 |
| Basic Earnings Per Share |
2.44%
0.84
|
0.82 | - | 0.82 | 0.94 |
| Diluted Earnings Per Share |
2.44%
0.84
|
0.82 | 0.80 | 0.82 | 0.94 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):